Spontaneous Degenerative Aortic Valve Disease in New Zealand Obese Mice

Christiane Ott1,2, Kathleen Pappritz2,3, Niklas Hegemann2,4

  • 1Department of Molecular Toxicology German Institute of Human Nutrition Potsdam-Rehbruecke Germany.

Insights

Naïve New Zealand obese mice spontaneously develop aortic valve disease and stenosis, leading to heart and lung failure. This new model mimics human degenerative aortic valve disease, aiding research into mechanisms and therapies.

Area of Science:

  • Cardiovascular Biology
  • Translational Medicine
  • Murine Models

Background:

  • Degenerative aortic valve (AoV) disease and aortic stenosis are significant clinical challenges.
  • A lack of suitable murine models hinders understanding of AoV disease mechanisms and therapeutic development.
  • Naïve New Zealand obese (NZO) mice exhibit early-onset left ventricular (LV) dysfunction.

Purpose of the Study:

  • To investigate the cause of reduced LV function in NZO mice.
  • To characterize the spontaneous development of AoV disease in NZO mice.
  • To establish NZO mice as a novel model for degenerative AoV disease research.

Main Methods:

  • Serial echocardiography to assess cardiac function and pulmonary hemodynamics in NZO and C57BL/6J mice.
  • Detailed analysis of aortic valve morphology and aortic flow dynamics.
  • Histopathological examination for LV remodeling, fibrosis, and inflammation.

Main Results:

  • NZO mice exhibited thickened AoVs with abnormal leaflet formation and cartilaginous changes.
  • Doppler echocardiography revealed aortic stenosis, regurgitation, and ascending aorta dilatation.
  • Progressive LV hypertrophy, decompensation, fibrosis, inflammation, and pulmonary hypertension with right ventricular failure were observed.

Conclusions:

  • NZO mice spontaneously develop degenerative AoV disease, mimicking human aortic stenosis.
  • This model exhibits significant end-organ damage in both ventricles and the lungs.
  • The NZO mouse model offers a valuable platform for mechanistic studies and testing therapies for degenerative AoV disease.

Related Concept Videos